Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRaw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Inventory (2024 - 2025)

Historic Inventory for Outlook Therapeutics (OTLK) over the last 2 years, with Q4 2025 value amounting to $3.5 million.

  • Outlook Therapeutics' Inventory rose 1121.33% to $3.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $3.5 million, marking a year-over-year increase of 1121.33%. This contributed to the annual value of $3.3 million for FY2025, which is N/A changed from last year.
  • Per Outlook Therapeutics' latest filing, its Inventory stood at $3.5 million for Q4 2025, which was up 1121.33% from $3.3 million recorded in Q3 2025.
  • Over the past 5 years, Outlook Therapeutics' Inventory peaked at $4.1 million during Q2 2025, and registered a low of $3.1 million during Q4 2024.